AR086789A1 - Comprimido masticable de ibuprofeno - Google Patents

Comprimido masticable de ibuprofeno

Info

Publication number
AR086789A1
AR086789A1 ARP120102328A ARP120102328A AR086789A1 AR 086789 A1 AR086789 A1 AR 086789A1 AR P120102328 A ARP120102328 A AR P120102328A AR P120102328 A ARP120102328 A AR P120102328A AR 086789 A1 AR086789 A1 AR 086789A1
Authority
AR
Argentina
Prior art keywords
ibuprofen
tablet
masticable tablet
masticable
refers
Prior art date
Application number
ARP120102328A
Other languages
English (en)
Original Assignee
Sino American Tianjin Smithkline And French Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45005458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR086789(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sino American Tianjin Smithkline And French Lab Ltd filed Critical Sino American Tianjin Smithkline And French Lab Ltd
Publication of AR086789A1 publication Critical patent/AR086789A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente se refiere a un comprimido masticable de ibuprofeno de sabor enmascarado y comprimido directamente que comprende una cantidad terapéuticamente eficaz de ibuprofeno que tiene un tamaño medio de partícula entre 250 mm y 400 mm, y un vehículo farmacéuticamente aceptable.
ARP120102328A 2011-07-01 2012-06-28 Comprimido masticable de ibuprofeno AR086789A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110182886A CN102258490B (zh) 2011-07-01 2011-07-01 布洛芬咀嚼片

Publications (1)

Publication Number Publication Date
AR086789A1 true AR086789A1 (es) 2014-01-22

Family

ID=45005458

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102328A AR086789A1 (es) 2011-07-01 2012-06-28 Comprimido masticable de ibuprofeno

Country Status (10)

Country Link
US (1) US20140134245A1 (es)
EP (1) EP2726063A4 (es)
CN (1) CN102258490B (es)
AP (1) AP3309A (es)
AR (1) AR086789A1 (es)
CO (1) CO6900137A2 (es)
PE (1) PE20140996A1 (es)
RU (1) RU2567050C2 (es)
TW (1) TW201315462A (es)
WO (1) WO2013004123A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104000791A (zh) * 2014-06-10 2014-08-27 安徽省逸欣铭医药科技有限公司 一种柠檬酸铁咀嚼片
CN104434832A (zh) * 2014-12-05 2015-03-25 海南卫康制药(潜山)有限公司 一种布洛芬组合物咀嚼片及其制备方法
ES2895113T3 (es) * 2015-11-18 2022-02-17 Hermes Pharma Gmbh Composiciones de ibuprofeno para administración oral directa
EP3860599B1 (en) 2018-10-04 2024-05-15 Adeptio Pharmaceuticals Limited (+)-alpha-dihydrotetrabenazine dosage regimen for treating movement disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1078140A (zh) * 1992-04-27 1993-11-10 陈晓华 高生物利用度布洛芬片的制备方法
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US6099865A (en) * 1998-07-08 2000-08-08 Fmc Corporation Croscarmellose taste masking
US20020122823A1 (en) * 2000-12-29 2002-09-05 Bunick Frank J. Soft tablet containing dextrose monohydrate
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION
AU2007308986A1 (en) * 2006-10-25 2008-05-02 Mcneil-Ppc, Inc. Ibuprofen composition
CN101390844B (zh) * 2007-09-23 2011-11-09 天津医科大学 精氨酸布洛芬片剂及其制备方法
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法

Also Published As

Publication number Publication date
EP2726063A4 (en) 2015-02-25
AP3309A (en) 2015-06-30
EP2726063A1 (en) 2014-05-07
US20140134245A1 (en) 2014-05-15
CN102258490A (zh) 2011-11-30
CN102258490B (zh) 2012-10-03
AP2013007326A0 (en) 2013-12-31
CO6900137A2 (es) 2014-03-20
WO2013004123A1 (en) 2013-01-10
TW201315462A (zh) 2013-04-16
PE20140996A1 (es) 2014-09-11
RU2567050C2 (ru) 2015-10-27
RU2014103479A (ru) 2015-08-10

Similar Documents

Publication Publication Date Title
USD698985S1 (en) Lighting fixture
USD700387S1 (en) Light fixture
AR115939A2 (es) Composición que contiene palmitoil-etanolamida ultra-micronizada
WO2015019284A3 (en) Inhibition of cxcr4 signaling in cancer immunotherapy
USD683063S1 (en) Lighting fixture
USD671668S1 (en) Lighting fixture
USD674127S1 (en) Lighting fixture
SMT201600007B (it) Liposomi con lipidi aventi valore pka vantaggioso per la somministrazione di rna
EA201500857A1 (ru) Комбинированные вакцины с синтетическими наноносителями
MY163083A (en) Solid forms of a pharmaceutically active substance
CL2012002404A1 (es) Compuestos derivados de urea, inhibidores de inmunoproteasomas; composición farmacéutica que comprende al compuesto; utiles en enfermedades inmunes, cancer, inflamacion, infecciones, enfermedad neurodegenerativa, entre otras.
CR20140044A (es) Dispositivo de cámara dual
IT1400876B1 (it) Metodo per incrementare e regolare l'emissione di luce da una reazione chemiluminescente.
MX367210B (es) Soluciones orales estables para api combinados.
USD660355S1 (en) Military data form
USD678420S1 (en) Sign holder
AR086789A1 (es) Comprimido masticable de ibuprofeno
AR082215A1 (es) Composicion farmaceutica agradable al paladar
ECSP15010550A (es) Preparación farmacéutica sólida que contiene levotiroxina
CR20110533A (es) Compuesto de pirazol
SV2011003919A (es) Extrudidos con sustancias activas con forma de agujas
AR093252A1 (es) Composicion farmaceutica oral utilizada como antiparasitaria y antidiarreica y procesos para prepararla
CU24209B1 (es) Composición farmacéutica en forma de una suspensión oral que comprende una fracción flavonoica y goma de xantano
USD676081S1 (en) Type font
USD663917S1 (en) Necktie

Legal Events

Date Code Title Description
FB Suspension of granting procedure